ProPhase Labs Inc [NASDAQ: PRPH] stock went on an upward path that rose over 1.41% on Monday, amounting to a one-week price decrease of less than -40.01%.
Over the last 12 months, PRPH stock dropped by -94.49%. The one-year ProPhase Labs Inc stock forecast points to a potential upside of 98.31. The average equity rating for PRPH stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $6.38 million, with 23.87 million shares outstanding and 20.54 million shares in the current float. Compared to the average trading volume of 335.60K shares, PRPH stock reached a trading volume of 14994688 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on ProPhase Labs Inc [PRPH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PRPH shares is $16.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PRPH stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for ProPhase Labs Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 20, 2021. The new note on the price target was released on October 13, 2021, representing the official price target for ProPhase Labs Inc stock. Previously, the target price had yet another raise to $25, while Dawson James analysts kept a Buy rating on PRPH stock.
The Average True Range (ATR) for ProPhase Labs Inc is set at 0.09, with the Price to Sales ratio for PRPH stock in the period of the last 12 months amounting to 0.50. The Price to Book ratio for the last quarter was 0.13, with the Price to Cash per share for the same quarter was set at 0.05.
PRPH Stock Performance Analysis:
ProPhase Labs Inc [PRPH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -40.01. With this latest performance, PRPH shares dropped by -64.73% in over the last four-week period, additionally sinking by -91.10% over the last 6 months – not to mention a drop of -94.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PRPH stock in for the last two-week period is set at 24.01, with the RSI for the last a single of trading hit 19.19, and the three-weeks RSI is set at 26.73 for ProPhase Labs Inc [PRPH]. The present Moving Average for the last 50 days of trading for this stock 0.6476, while it was recorded at 0.3726 for the last single week of trading, and 2.6646 for the last 200 days.
Insight into ProPhase Labs Inc Fundamentals:
ProPhase Labs Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.33 and a Current Ratio set at 1.47.
ProPhase Labs Inc [PRPH] Institutonal Ownership Details
There are presently around $7.63%, or 8.91%% of PRPH stock, in the hands of institutional investors. The top three institutional holders of PRPH stocks are: VANGUARD GROUP INC with ownership of 0.66 million shares, which is approximately 3.6351%. RENAISSANCE TECHNOLOGIES LLC, holding 0.22 million shares of the stock with an approximate value of $$0.92 million in PRPH stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$0.63 million in PRPH stock with ownership which is approximately 0.8389%.
